The levels of immune suppressive cytokines IL-10, TGF-β, and nitric oxide were also highly reduced, further showing low-dose CPX’s ability to shift the immune response phenotype to an anti-tumor, cell-mediated Th1 phenotype. This evidence concerns the gene IL10 and neoplasm.